Cytek Biosciences (CTKB)

Cytek Biosciences (CTKB) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CTKB last traded at $5.40, -8.16% on the day.
• Cytek Biosciences: P/E -8.5, revenue $207.65M over the last four quarters.
• Over the past year CTKB returned 34.66%; year to date 6.93%.

Updated 2026-11-06 11:45 UTC